Yemaachi Biotech Alternatives & Competitors
12 companies similar to Yemaachi Biotech — Developing new anti-cancer drugs that are effective in diverse populations | YC...
Companies similar to Yemaachi Biotech
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
Fore Biotherapeutics
A precision oncology company rooted in science and innovation, developing cancer therapies...
Philadelphia, United Stat...
VaxCell Biotherapeutics Co., Ltd.
The Better life with Anti-cancer immunotherapy
Korea South
Rival Readout
Competing with Yemaachi Biotech? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Hemispherian AS
Hemispherian is a biotechnology company developing new treatments for the most aggressive...
Oslo, Norway
Ludwig Cancer Research
We are a global community of leading scientists pursuing innovative ways to prevent and co...
New York, United States
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Israel
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
MAX BioPharma, Inc.
Pioneering new treatments for severe and life-threatening illnesses through innovative sma...
Santa Monica, United Stat...
PIC Therapeutics
Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes
Natick, United States
Craif Inc.
Harnessing the power of urinary miRNA to detect cancer early
Irvine, United States
About Yemaachi Biotech
Yemaachi Biotech is a biotechnology startup founded in 2020 and based in Ghana. The company's slogan "Developing new anti-cancer drugs that are effective in diverse populations" reflects their focus on addressing the global need for inclusive cancer treatments. Their recent Seed Round saw an investment of $3.00M from a...
Anti-cancer Drugs, Cancer Treatment, Innovation, Diverse Populations, Africa, Global Health, Medical Research, Startups, Investing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Yemaachi Biotech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Yemaachi Biotech on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
